RxDoctor Payments Data

Saikrishna Gourishetti, MD

Otolaryngology · Baltimore, MDNPI 1427552207

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,768 of the $2,902 with a category attached, or 60.9%. 12 manufacturers reported payments, led by Stryker at 54.6% of the total. Reporting peaked in 2023 at $1,855 and has fallen 67.3% since, to $606 in 2025.

$2,902in general payments, 2019–2025

Across 33 payments — averaging $87.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Johnson & Johnson$442
  • Kerecis Limited$224
  • Acera Surgical, Inc.$150
  • Aroa Biosurgery Incorporated$141
  • Inspire Medical Systems, Inc.$121
  • plus $238 from 6 others

What the payments were for

  • Travel & lodging$1,13439%
  • Food & beverage$1,76861%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,902 in reported general payments places this provider in the 75th percentile of 222 otolaryngology providers in Maryland.

See all otolaryngology providers in Maryland

Medicare billing

Part B allowed, 2024
$28,782
Medicare patients
58
Services billed
220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin13$45

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →